IBIan Beddows

Ian Beddows

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ian Beddows has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Compartment-Resolved Profiling Identifies Shared Stromal Programs and Clarifies Molecular Subtype Origins in Ovarian Cancer

    by Svetlana Djirackor, Karolin Heinze, Ian Beddows, David Sokol, Bianca Ribeiro de Souza, Marie Adams, Martin Köbel, Michael S. Anglesio, Hui Shen

    Epithelial ovarian cancers (EOCs) comprise biologically distinct histotypes that arise within shared anatomical niches where tumor–stroma interactions shape tumor behavior and therapeutic response. However, most classification frameworks rely on bulk profiling that conflates epithelial and stromal contributions, limiting the understanding of crosstalk between the different compartments. Here, we performed compartment-resolved transcriptomic and epigenomic profiling of matched carcinoma and stroma across clear cell (CCOC), endometrioid (ENOC), and high-grade serous ovarian cancers (HGSC). Carcinoma profiles segregated strongly by histotype, whereas stromal profiles showed minimal histotype specificity and instead resolved into four shared groups (S1–S4). The S4 subtype, marked by a desmoplastic, myofibroblast-rich program, was enriched in omental tumors and corresponded to the HGSC C1/Mesenchymal signature. This subtype largely reflected tumor-extrinsic programs and was present beyond HGSC. Compartment-resolved analyses also refined the interpretation of other molecular carcinoma subtypes and revealed distinct carcinoma-intrinsic EMT-like programs. Together, these findings define a histotype-agnostic stromal architecture across epithelial ovarian cancers, clarify the cellular basis of canonical high-grade serous molecular subtypes, and reveal carcinoma-intrinsic EMT programs. This study underscores the value of physically separating epithelial and stromal compartments before molecular analysis and position this dataset as a multi-purpose reference resource for the EOC research community.

  • Open Access

    Tranquillyzer: A Neural Network Framework for Long-read Annotation and Demultiplexing

    by Ayush Semwal, Jacob Morrison, Ian Beddows, Theron Palmer, Mary F Majewski, H Josh Jang, Benjamin K Johnson, Hui Shen

    Long-read single-cell RNA sequencing enables full-length transcript profiling but remains limited by challenges in interpreting structurally complex sequencing reads. High error rates, heterogeneous library designs, and frequent molecular artifacts disrupt barcode and UMI detection, while existing pipelines rely on positional heuristics that fail when structural elements are shifted, truncated, rearranged, or concatenated. Here, we introduce Tranquillyzer, a deep learning framework for global, context-aware structural inference of long-read molecules. Tranquillyzer performs base-resolution annotation of sequencing reads by modeling their full architectural context, enabling accurate identification of adapters, barcodes, UMIs, and transcript segments even under substantial sequencing noise and structural variability. Across simulated benchmarks, Tranquillyzer achieved > 99.7% structural filtering accuracy, > 91% demultiplexing efficiency, and > 99.9% demultiplexing accuracy, substantially exceeding existing methods. Tranquillyzer supports standard long-read single-cell protocols and can be rapidly trained to interpret custom library architectures. Its scalable processing and read-level visualization enable systematic detection of complex molecular artifacts, including multi-fragment chimeras. By enabling reliable structural parsing of long-read libraries, Tranquillyzer provides a generalizable framework for structural interpretation of single-cell and bulk long-read sequencing data. Tranquillyzer is freely available at: https://github.com/huishenlab/Tranquillyzer.

  • Open Access

    Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription

    by Rebecca Kaufman, Guillermo Flores, Elissa A. Boguslawski, Seneca Kinn-Gurzo, Maggie Chassé, Ian Beddows, Marie Adams, Matthew C. Stout, Lauren Gaetano, Raphael Lopez, et al.

    Although many DNA binding natural products exert their effects through non-specific mechanisms, a therapeutic opportunity exists for a subset of these compounds that alter the expression or activity of specific driver oncogenes in specific cell contexts. In this study, we integrate CUT&Tag with Global Run-On Sequencing (CUT, Tag, and GRO) to show that the minor groove binding compound, mithramycin (MMA), inhibits the Ewing sarcoma oncogenic driver, the EWS::FLI1 transcription factor. MMA causes either an increase or decrease in EWS::FLI1 binding to chromatin at downstream target response elements to poison nascent transcription. The reversal of EWS::FLI1 activity is limited by non-specific effects of the drug on RNAPII processivity but can be optimized by continuous administration at low concentration to cause more precise reversal of the oncogenic transcriptome and striking Ewing sarcoma xenograft regressions. The activity in vivo is further improved with a less-toxic second-generation analog, AIT-102.


  • Open Access

    Tranquillyzer: A Flexible Neural Network Framework for Structural Annotation and Demultiplexing of Long-Read Transcriptomes

    by Ayush Semwal, Jacob Morrison, Ian Beddows, Theron Palmer, Mary F. Majewski, H. Josh Jang, Benjamin K. Johnson, Hui Shen

    Long-read single-cell RNA sequencing using platforms such as Oxford Nanopore Technologies (ONT) enables full-length transcriptome profiling at single-cell resolution. However, high sequencing error rates, diverse library architectures, and increasing dataset scale introduce major challenges for accurately identifying cell barcodes (CBCs) and unique molecular identifiers (UMIs) - key prerequisites for reliable demultiplexing and deduplication, respectively. Existing pipelines rely on hard-coded heuristics or local transition rules that cannot fully capture this broader structural context and often fail to robustly interpret reads with indel-induced shifts, truncated segments, or non-canonical element ordering. We introduce Tranquillyzer (TRANscript QUantification In Long reads-anaLYZER), a flexible, architecture-aware deep learning framework for processing long-read single-cell RNA-seq data. Tranquillyzer employs a hybrid neural network architecture and a global, context-aware design, and enables precise identification of structural elements - even when elements are shifted, partially degraded, or repeated due to sequencing noise or library construction variability. In addition to supporting established single-cell protocols, Tranquillyzer accommodates custom library formats through rapid, one-time model training on user-defined label schemas, typically completed within a few hours on standard GPUs. Additional features such as scalability across large datasets and comprehensive visualization capabilities further position Tranquillyzer as a flexible and scalable framework solution for processing long-read single-cell transcriptomic datasets.


  • Open Access

    YAP signaling promotes resistance to MEK and AKT inhibition in NF1 -related MPNSTs

    by Lauren E. McGee, Jamie L. Grit, Curt J. Essenburg, Sophia Agrusa, Elizabeth A. Tovar, Lisa Turner, Katelyn Becker, Jason Zbieg, Anwesha Dey, Jennifer E. Klomp, et al.

    Neurofibromatosis type 1 (NF1) is a tumor predisposition syndrome caused by loss of function of the neurofibromin protein. Malignant peripheral nerve sheath tumors (MPNSTs) are a rare and deadly sarcoma with few therapeutic options that are the leading cause of death for patients with NF1. To date, no targeted therapies have been approved for MPNST treatment, highlighting the need for an understanding of adaptive signaling mechanisms that drive resistance. We developed a preclinical model of drug resistance using a cross-over drug holiday design and evaluated patterns of response and resistance to MEK and AKT inhibitors, two pathways that are dysregulated by loss of neurofibromin. We show that the mTOR and YAP/TEAD pathways are activated by MEK inhibitor exposure, yet blockade of these pathways in resistant MPNST PDX models does not significantly reduce tumor growth, despite strong in vitro synergy between trametinib and the novel TEAD inhibitor, GNE-7883. Using spatial transcriptomics, we uncovered phenotypic inertia as a key mechanism of drug resistance in MPNST, in addition to signaling plasticity. Further, we found that resistance is mediated by sustained ERK, YAP, and MYC driven transcriptional programs. In the future, preclinical studies should focus on addressing intratumoral heterogeneity and how it evolves over time.

  • Open Access

    Supplementary Table 1 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation

    by Geyon L. Garcia, Taylor Orellana, Grace Gorecki, Leonard Frisbie, Roja Baruwal, Swathi Suresh, Ester Goldfeld, Ian Beddows, Ian P. MacFawn, Ananya K. Britt, et al.

    Supplementary Table 1 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation

  • Open Access

    Supplementary Figure 2 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation

    by Geyon L. Garcia, Taylor Orellana, Grace Gorecki, Leonard Frisbie, Roja Baruwal, Swathi Suresh, Ester Goldfeld, Ian Beddows, Ian P. MacFawn, Ananya K. Britt, et al.

    Supp. Figure 2 A) Unmodified principal component analysis. B) WT1 MFI in CA-MSCs and nMSCs. The lower limit of CA-MSC WT1 MFI was used to classify hrMSCs. C) Proliferation assay (full time course) using ovarian cancer cells and shRNA knockdown MSCs. Scramble shRNA and tumor cells alone are shown. D) Tissue culture treated plates were coated with poly-D-lysine. This served as a positive control for adherence assays. FT190 control cells and OVSAHO tumor cells were utilized. P-values are shown. P-values were determined by Student’s T-test.

  • Open Access

    Supplementary Table 2 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation

    by Geyon L. Garcia, Taylor Orellana, Grace Gorecki, Leonard Frisbie, Roja Baruwal, Swathi Suresh, Ester Goldfeld, Ian Beddows, Ian P. MacFawn, Ananya K. Britt, et al.

    Supplementary data AMPK related DEG list

  • Open Access

    Supplementary Figure 4 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation

    by Geyon L. Garcia, Taylor Orellana, Grace Gorecki, Leonard Frisbie, Roja Baruwal, Swathi Suresh, Ester Goldfeld, Ian Beddows, Ian P. MacFawn, Ananya K. Britt, et al.

    Supp. Figure 4 A) Representative images of organoids that were injected into NSG mice. FTE and MSCs were seeded at a 1:1 ratio under non-adherent conditions. FTE are labelled in red while hrMSCs are labelled in blue.B) Representative image of pancytokeratin IHC of tumor resulting from organoid implanted in vivo demonstrating human epithelial origin.

  • Open Access

    Supplementary Figure 6 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation

    by Geyon L. Garcia, Taylor Orellana, Grace Gorecki, Leonard Frisbie, Roja Baruwal, Swathi Suresh, Ester Goldfeld, Ian Beddows, Ian P. MacFawn, Ananya K. Britt, et al.

    Supp. Figure 6 A) MDA adduct ELISA comparing nMSC and hrMSC conditioned media. Individual data points represent individual patient cell lines. Statistics were determined by the student’s T-test. B) Western blot validation of GW4969 effect on MSCs. Conditioned media was ultracentrifuged to remove large EVs (>500 µm) and exosomes (<500 µm). EV lysates were probed for CD36 expression. C) IF validation of EV transfer. MSCs were labelled with BODIPY C-12 and media was collected after an overnight incubation. Media was spun to remove debris and added to epithelial cells. Epithelial cells were screened for BODIPY positivity. D) MSCs were stained with BODIPY C-12, allowed to rest for 1hr, then media was removed, spun to remove debris, and added to FTE. FTE were analyzed by flow cytometry for BODIPY C-12 positivity. P-values are shown. P-values were determined by the student’s t-test.